News

Viorra is a non-invasive topical treatment to assist women who are suffering from a range of female sexual arousal disorders (FSAD) that cause a lack of vaginal lubricity

Avastin is a prescription-only medicine that is a solution for intravenous infusion. In the trial, the women who received Avastin showed 52% reduction in the risk of their

Before joining Asmacure, Driscoll served as the CEO and director of Javelin Pharmaceuticals, a developer of acute care pain products. Prior to Javelin, Driscoll held senior positions in

Semuloparin is an investigational selectively engineered Ultra-LMWH (low molecular weight heparin) with enriched anti-thrombin binding sites. Semuloparin reduced the risk of this type of blood clots without increasing

The results from the trial suggested that at five years 66% of patients taking Glivec for three years remained free of cancer recurrence (primary endpoint) compared to 48%

Developed by Genentech and Novartis, Lucentis is an antibody fragment that is injected into the eye and acts by neutralizing VEGF. The EC’s approval was given on the

In addition to being an investigational pan-BCR-ABL inhibitor for use in chronic myeloid leukemia (CML), ponatinib inhibits certain other tyrosine kinases, including a specific mutation of FLT3 called

The double-blind, placebo-controlled study is designed to measure the efficacy, safety and tolerability of STX209, an oral selective gamma-amino butyric acid type B (GABA-B) receptor agonist. GABA-B receptors

Under the agreement, Biowa will receive the right to certain antibody technology from IMUC and selected option rights to IMUC antibodies using the POTELLIGENT Technology. POTELLIGENT Technology involves